AAgilent Technologies, Inc.

$32B

Q1 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.2B+13.5% YoY

Gross Profit

$673M55.6% margin

Operating Income

$229M18.9% margin

Net Income

-$320M-26.4% margin

EPS (Diluted)

$-0.99

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$215M

Free Cash Flow

$155M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$8.7B

Total Liabilities

$4.2B

Stockholders' Equity

$4.5B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+13.5%
Gross Profit	$673M	$574M	+17.2%
Operating Income	$229M	$206M	+11.2%
Net Income	-$320M	$168M	-290.5%

Revenue Segments

Life Sciences and Applied Markets

$618M51%

Agilent CrossLab

$408M34%

Diagnostics and Genomics

$185M15%

A Q1 2018 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena